Christopher A. Viehbacher removed as Sanofi’s Chief Executive Officer

Sanofi’s Board of Directors have decided unanimously to remove Christopher A. Viehbacher as Chief Executive Officer of Sanofi. As a consequence Christopher A. Viehbacher resigned as a director of Sanofi.

Sanofi’s Board of Directors thanked Christopher A. Viehbacher for all the work done during the last six years, which enabled the Group to move through a sensitive and important transition phase.

Going forward, Sanofi have said that the Group needs to pursue its development with a management aligning the teams, harnessing talents and focusing on execution with a close and confident cooperation with the Board. 

Sanofi have confirmed its commitment to continuing its strategy and the international expansion of the Group based on research and innovation and its growth platforms. 

Pending the decision on the appointment of a new Chief Executive Officer, Sanofi’s Board asked Serge Weinberg to fulfill jointly, as of today and on a temporary basis, the functions of Chairman and Chief Executive Officer. As soon as a new Chief Executive Officer is appointed, the Group’s governance will return to a Chairman and a separate Chief Executive Officer.